Historical Valuation
HCA Healthcare Inc (HCA) is now in the Overvalued zone, suggesting that its current forward PE ratio of 16.02 is considered Overvalued compared with the five-year average of 13.82. The fair price of HCA Healthcare Inc (HCA) is between 391.82 to 469.32 according to relative valuation methord. Compared to the current price of 475.47 USD , HCA Healthcare Inc is Overvalued By 1.31%.
Relative Value
Fair Zone
391.82-469.32
Current Price：475.47
1.31%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
HCA Healthcare Inc (HCA) has a current Price-to-Book (P/B) ratio of -20.27. Compared to its 3-year average P/B ratio of -35.09 , the current P/B ratio is approximately -42.25% higher. Relative to its 5-year average P/B ratio of -22.40, the current P/B ratio is about -9.54% higher. HCA Healthcare Inc (HCA) has a Forward Free Cash Flow (FCF) yield of approximately 7.54%. Compared to its 3-year average FCF yield of 6.40%, the current FCF yield is approximately 17.91% lower. Relative to its 5-year average FCF yield of 6.25% , the current FCF yield is about 20.67% lower.
P/B
Median3y
-35.09
Median5y
-22.40
FCF Yield
Median3y
6.40
Median5y
6.25
Competitors Valuation Multiple
AI Analysis for HCA
The average P/S ratio for HCA competitors is 1.19, providing a benchmark for relative valuation. HCA Healthcare Inc Corp (HCA.N) exhibits a P/S ratio of 1.37, which is 15.54% above the industry average. Given its robust revenue growth of 9.57%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for HCA
1Y
3Y
5Y
Market capitalization of HCA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HCA in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HCA currently overvalued or undervalued?
HCA Healthcare Inc (HCA) is now in the Overvalued zone, suggesting that its current forward PE ratio of 16.02 is considered Overvalued compared with the five-year average of 13.82. The fair price of HCA Healthcare Inc (HCA) is between 391.82 to 469.32 according to relative valuation methord. Compared to the current price of 475.47 USD , HCA Healthcare Inc is Overvalued By 1.31% .
What is HCA Healthcare Inc (HCA) fair value?
HCA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of HCA Healthcare Inc (HCA) is between 391.82 to 469.32 according to relative valuation methord.
How does HCA's valuation metrics compare to the industry average?
The average P/S ratio for HCA's competitors is 1.19, providing a benchmark for relative valuation. HCA Healthcare Inc Corp (HCA) exhibits a P/S ratio of 1.37, which is 15.54% above the industry average. Given its robust revenue growth of 9.57%, this premium appears unsustainable.
What is the current P/B ratio for HCA Healthcare Inc (HCA) as of Jan 09 2026?
As of Jan 09 2026, HCA Healthcare Inc (HCA) has a P/B ratio of -20.27. This indicates that the market values HCA at -20.27 times its book value.
What is the current FCF Yield for HCA Healthcare Inc (HCA) as of Jan 09 2026?
As of Jan 09 2026, HCA Healthcare Inc (HCA) has a FCF Yield of 7.54%. This means that for every dollar of HCA Healthcare Inc’s market capitalization, the company generates 7.54 cents in free cash flow.
What is the current Forward P/E ratio for HCA Healthcare Inc (HCA) as of Jan 09 2026?
As of Jan 09 2026, HCA Healthcare Inc (HCA) has a Forward P/E ratio of 16.02. This means the market is willing to pay $16.02 for every dollar of HCA Healthcare Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for HCA Healthcare Inc (HCA) as of Jan 09 2026?
As of Jan 09 2026, HCA Healthcare Inc (HCA) has a Forward P/S ratio of 1.37. This means the market is valuing HCA at $1.37 for every dollar of expected revenue over the next 12 months.